Higher daily step counts associated with fewer depressive symptoms

A systematic review reveals that walking 7,000+ steps daily is associated with lower depression risk, underscoring physical activity’s role in mental health.

Pα+ Psychedelic Bulletin #171: Lykos Criticises AdComm Process; Cybin’s Plan to Handle Functional Unblinding; Doblin Charts a Future for MAPS; DEA Plots Ketamine Crackdown – Psychedelic Alpha

In this Issue Lykos CEO Provides AdComm Feedback to FDA Commissioner Cybin Plans to Fight Functional Unblinding with ‘Firewall’ Doblin Charts a Future for MAPS

August 30, 2024

What does it mean to be ‘in recovery’? We need a better federal definition

“When I use a word,” one of 19th century British author and mathematician Lewis Carroll’s characters once said, “it means just what I choose it

July 11, 2023

FDA advisers unanimously recommend approval of Eli Lilly’s Alzheimer’s disease treatment

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli

June 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.